Contract facts
FederalNo full NAICS 325412 intel page yet. Browse NAICS intelligence
INO THERAPEUTICS INC:1107599 [26-001138] is a federal award for National Institutes Of Health - Cc held by Ino Therapeutics LLC. Estimated value $115K ($40K obligated). Current period of performance ends Feb 28, 2027. Last award drew 1 bidder. Place of performance: HAMPTON NJ. Related solicitation RFQ1704890.
Recompete timing
PublicCurrent PoP ends Feb 28, 2027 (191 days remaining). Agencies typically plan 12–18 months ahead — at 6.3 months out, that window is already open. The buying decision is likely already in motion.
Incumbent footprint
Public recordIno Therapeutics LLC — $2.5M obligated across 84 awards (firm-wide, all agencies) · lead buyer Department of Defense (DOD).
Related awards
Same parent · incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 75N90024F00080?
75N90024F00080 (INO therapeutics inc:1107599 [26-001138) is a National Institutes Of Health - Cc award with a potential value of $115K, currently held by Ino Therapeutics LLC. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
Which office awarded 75N90024F00080?
National Institutes Of Health - Cc awarded 75N90024F00080 to Ino Therapeutics LLC (potential $115K).
Who is the incumbent on 75N90024F00080?
Ino Therapeutics LLC is the incumbent with $2.5M across 84 related awards in SCOUT’s public footprint. The current period of performance ends Feb 28, 2027.
When does Ino Therapeutics LLC’s 75N90024F00080 come up for recompete?
SCOUT tracks a period-of-performance end of Feb 28, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.